Moderna Makes $400M Payment To NIH For COVID-19 Vaccine Technique

The New York Times (2/23, Mueller) reports, “As Moderna racked up tens of billions of dollars in sales of its coronavirus vaccine, the company held off on paying for the rights to a chemical technique that scientists said it had borrowed from government-f...